Supplement AERs
This article was originally published in The Tan Sheet
Executive Summary
Boston Office of the Inspector General has completed research for a report investigating FDA's dietary supplement adverse event monitoring system. Report assesses system's postmarketing surveillance capabilities with regard to supplements and reported AEs. Draft will be circulated to interested government agencies, including FDA, for comment over next several weeks. HHS division hopes final version will be released around mid-April